DOCSLIB.ORG

Scientific Proceedings 2018 CVMA Convention

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Scientific Proceedings 2018 CVMA Convention Scientific Proceedings 2018 CVMA Convention Table of Contents THURSDAY, JULY 5, 2018. .................................................................................................................................................... 5 Business Management Track .............................................................................................................................................. 5 How to Train Your Millennial ................................................................................................................................................... 5 Show Me the Money! ................................................................................................................................................................ 7 Don’t Fear the Feedback .......................................................................................................................................................... 11 It’s All in the Family: Creating a Team Culture ...................................................................................................................... 15 Becoming a Loving Leader ..................................................................................................................................................... 17 FRIDAY, JULY 6, 2018. ......................................................................................................................................................... 22 Companion Animal: Dentistry ......................................................................................................................................... 22 Clandestine Oral Pathology Missed on Examination But Captured With Introral Dental Radiography ................................. 22 Ophthalmological and Maxillofacial Manifestations of Dental Disease ................................................................................. 28 Oral Masses in the Dog and Cat: The Eye is not a Microscope ............................................................................................... 33 Feline Oral Inflammation and Treatment Updates .................................................................................................................. 39 Recognizing the Clinical Significance of Malocclusions and Developmental Tooth Defects in the Dog ............................... 45 The Senior and Geriatric Dental patient: Age Should Not Preclude Treatment ...................................................................... 53 Companion Animal: Soft Tissue Surgery ........................................................................................................................ 55 Salivary Gland Removal: Ventral or Lateral Approach – Which One Should I do? ............................................................... 55 Surgical Diseases of the Spleen: How you can Avoid Trouble! .............................................................................................. 58 Prophylactic Gastropexy: When? How?`................................................................................................................................. 63 Companion Animal: IVPAM: Pain Management........................................................................................................... 66 Making Sense of Pathophysiology of pain in a Clinical Context ............................................................................................ 66 All the Reasons Why Cancer Hurts ......................................................................................................................................... 68 Chronic Pain in Cats: From Recognition to Treatment ............................................................................................................ 72 Companion Animal: Endocrinology ................................................................................................................................ 75 Cushing’s Disease: Something New, Something Blue ............................................................................................................ 75 Hypoadrenocorticism ............................................................................................................................................................... 78 Hyperthyroidism ...................................................................................................................................................................... 81 Companion Animal: Gastroenterology ............................................................................................................................ 84 GI Formulary ........................................................................................................................................................................... 84 Pancreatitis in Cats .................................................................................................................................................................. 86 The Cutting Edge of Medicine: What’s New in Gastroenterology .......................................................................................... 88 Ruminant: Bovine Medicine and Surgery ....................................................................................................................... 94 Umbilical Surgery: Hernias, Abscesses and Omphalophlbitis ................................................................................................ 94 The Bovine Abdomen: I’m In…Now What? ........................................................................................................................... 99 Lameness Beyond Footrot ..................................................................................................................................................... 102 Ruminant: Beef Cattle: Reproductive & Respiratory Diseases ................................................................................... 107 Diagnosing Infectious Reproductive Losses in Beef Cattle ................................................................................................... 107 Reproductive Vaccines in Beef Cattle: Current Concepts ..................................................................................................... 111 Pre-weaning Respiratory Disease in Cow-Calf Herds ........................................................................................................... 115 1 Equine: Field Anaesthesia and Analgesia ...................................................................................................................... 119 Physiological Approach to Equine Analgesia ........................................................................................................................ 119 Sedation for Standing Equine Procedures.............................................................................................................................. 125 Loco-regional Anaesthestic Techiniques for the Equine Head .............................................................................................. 131 Equine: Head and Surgery for the Field Practitioner .................................................................................................. 136 The Paranasal Sinuses for the Field Practitioner ................................................................................................................... 136 The Black Hole: The Guttural Pouch .................................................................................................................................... 140 Upper Airway Surgery for the Field Practitioner................................................................................................................... 144 Animal Welfare: Large Animal ...................................................................................................................................... 149 Animal Welfare in the Context of Social Sustainability ........................................................................................................ 149 Public Concerns About Animal Welfare: How Should the Industry Respond?..................................................................... 158 Care and Management of the Milk Fed Calf (von Keyserlingk) ........................................................................................... 167 Introduction ........................................................................................................................................................................... 167 Calf Feeding .......................................................................................................................................................................... 167 Group housing ....................................................................................................................................................................... 168 Conclusion ............................................................................................................................................................................. 170 Acknowledgement ................................................................................................................................................................. 170 Animal Welfare: Companion Animal: Animal Abuse .................................................................................................. 172 Session 1: The “Link”: Animal & Human Health Implications of Animal
Load more

Recommended publications
  • Arthroscopic Lavage
    Arthroscopic Lavage Arthroscopic lavage is a procedure to wash out any blood, fluid or loose pieces from inside the space between joints. It is commonly used to treat osteoarthritis, a form of arthritis that features the breakdown and eventual loss of the cartilage of one or more joints. What does OHIP fund? OHIP funds arthroscopic lavage procedures that are medically necessary. What changes are included in the 2012 Physician Services Agreement and why? Under the new agreement, arthroscopic knee lavage is no longer insured for the treatment of osteoarthritis, because it is an ineffective treatment. This change is based on clinical evidence which shows that this treatment does not improve symptoms and also does not delay surgery if needed. A 2007 best practice guideline from the National Institute for Health and Clinical Excellence in the United Kingdom states that there is no evidence to support arthroscopic knee lavage as a treatment for osteoarthritis. An evidence-based analysis the OHTAC recommended in 2005 against the use of arthroscopic lavage for osteoarthritis of the knee. OHTAC’s recommendations are as follows: o Arthroscopic debridement, a surgical procedure to remove damaged tissue in joints using a "scope", of the knee has so far only been found to be effective for osteoarthritis of the inner compartment of the knee. All other indications should be reviewed with a view to reducing arthroscopic debridement as an effective therapy. o Arthroscopic lavage of the knee alone (without debridement) is not recommended for any stage of osteoarthritis. This change will reduce unnecessary arthroscopic lavage procedures, saving the cost of the procedure and the time required for both physicians and patients.
    [Show full text]
  • Applications of Cytokeratin Expression in the Diagnosis of Oral Diseases
    Jemds.com Review Article Applications of Cytokeratin Expression in the Diagnosis of Oral Diseases Archana Sonone1, Alka Hande2, Madhuri Gawande3,Swati Patil4 1, 2, 3, 4 Department of Oral Pathology and Microbiology, Sharad Pawar Dental College, Datta Meghe Institute of Medical Sciences (Deemed to Be University) Sawangi (Meghe), Wardha, Maharashtra, India. ABSTRACT All mammalian cells have a complex intracytoplasmic cytoskeleton made up of three Corresponding Author: main structural units and related proteins, tubulin containing microtubules, actin Dr. Archana Sonone. Department of Oral Pathology and containing microfilaments, and Intermediate Filaments (IF). There are six types of Microbiology, Sharad Pawar Dental IFs; cytokeratin fibres consisting of type I and type II IFs. Cytokeratins (CK), College, Datta Meghe Institute of Medical . comprising of collections of IFs that are explicitly communicated by epithelial tissues Sciences (Deemed to Be University) There are 20 unique polypeptides of CK expressed by epithelium that have been Sawangi (Meghe), Wardha, Maharashtra, indexed based on their molecular weight (range 40-70 kDa). India. CK and associated filaments give a framework to epithelial cells and tissues to E-mail: [email protected] maintain their structural integrity. Thus, ensure mechanical resilience, sustain stress, establish cell polarity, and to protect against variations in hydrostatic pressure. DOI: 10.14260/jemds/2021/50 Genetic encoding of cytokeratins shows homogeneous “nucleotide sequence”. 54 How to Cite This Article: genes are responsible for encoding of cytokeratin in humans which are congregated Sonone A, Hande A, Gawande M, et al. on chromosome no. 2. Genetic mutation of cytokeratins is important for Applications of cytokeratin expression in pathophysiology of various mucocutaneous disorders, which is mostly autosomal the diagnosis of oral diseases.
    [Show full text]
  • Glossary for Narrative Writing
    Periodontal Assessment and Treatment Planning Gingival description Color: o pink o erythematous o cyanotic o racial pigmentation o metallic pigmentation o uniformity Contour: o recession o clefts o enlarged papillae o cratered papillae o blunted papillae o highly rolled o bulbous o knife-edged o scalloped o stippled Consistency: o firm o edematous o hyperplastic o fibrotic Band of gingiva: o amount o quality o location o treatability Bleeding tendency: o sulcus base, lining o gingival margins Suppuration Sinus tract formation Pocket depths Pseudopockets Frena Pain Other pathology Dental Description Defective restorations: o overhangs o open contacts o poor contours Fractured cusps 1 ww.links2success.biz [email protected] 914-303-6464 Caries Deposits: o Type . plaque . calculus . stain . matera alba o Location . supragingival . subgingival o Severity . mild . moderate . severe Wear facets Percussion sensitivity Tooth vitality Attrition, erosion, abrasion Occlusal plane level Occlusion findings Furcations Mobility Fremitus Radiographic findings Film dates Crown:root ratio Amount of bone loss o horizontal; vertical o localized; generalized Root length and shape Overhangs Bulbous crowns Fenestrations Dehiscences Tooth resorption Retained root tips Impacted teeth Root proximities Tilted teeth Radiolucencies/opacities Etiologic factors Local: o plaque o calculus o overhangs 2 ww.links2success.biz [email protected] 914-303-6464 o orthodontic apparatus o open margins o open contacts o improper
    [Show full text]
  • 11 GERIATRIC ORTHOPEDICS Susan Day, MD* by the Year 2020 About 20% of the Population, Or an Estimated 60 Million People, Will Be Aged 65 Years Or Over
    11 GERIATRIC ORTHOPEDICS Susan Day, MD* By the year 2020 about 20% of the population, or an estimated 60 million people, will be aged 65 years or over. Increasing age leads to increasing vulnerability in the musculo- skeletal system through injury and disease. Approximately 80% of those older persons will have musculoskeletal complaints. Significant osteoarthritis of the hip or knee will be reported by 40% to 60% of older persons. Disabling osteoarthritis of the weight-bearing joints commonly leads to joint replacement surgery, which was performed an average of 648,000 times annually from 1993 to 1995. 1 In 1996, 74% of the total knee replacements and 68% of the total hip replacements were performed on patients aged 65 and older. 1 As the number of elders in the population increases, so will the need for joint replacement surgery. Joint arthroplasty is expected to increase by at least 80% by 2030. 1 Age-related changes in bone and soft tissue are commonly associated with disabling fractures. In the first 5 years following menopause, women lose up to 25% of their bone mass. In the United States, osteoporosis affects approximately 20 million persons, and every year 1.3 million fractures are attributed to this condition. Muscle strength decreases on average by about one third after age 60, which can lead to difficulty maintaining balance and predispose a person to falls. By the age of 90, one third of women and one sixth of men will experience a hip fracture. About two thirds of those who fracture a hip do not return to their prefracture level of functioning.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • Panoramic Radiologic Appraisal of Anomalies of Dentition: Chapter 2
    Volume 3, Issue 2 US $6.00 Editor: Panoramic radiologic appraisal of Allan G. Farman, BDS, PhD (odont.), DSc (odont.), anomalies of dentition: Chapter #2 Diplomate of the By Dr. Allan G. Farman entiated from compound odonto- American Board of Oral mas. Compound odontomas are and Maxillofacial The previous chapter Radiology, Professor of encapsulated discrete hamar- Radiology and Imaging higlighted the sequential nature of tomatous collections of den- Sciences, Department of developmental anomalies of the ticles. Surgical and Hospital dentition in general missing teeth Recognition of supernumerary Dentistry, The University of in particular. This chapter provides teeth is essential to determining Louisville School of discussion supernumerary teeth appropriate treatment [2]. Diag- Dentistry, Louisville, KY. and anomalies in tooth size. nosis and assessment of the Supernumeraries: mesiodens is critical in avoiding Featured Article: Supernumeraries are present when complications such as there is a greater than normal impedence in eruption of the Panoramic radiologic complement of teeth or tooth maxillary central incisors, cyst appraisal of anomalies of follicles. This condition is also formation, and dilaceration of the dentition: Chapter #2 termed hyperodontia. The fre- permanent incisors. Collecting quency of supernumerary teeth in data for diagnostic criteria, In The Recent Literature: a normal population is around 3 % utilizing diagnostic radiographs, [1]. Most supernumeraries are found and determining when to refer to Impacted canines in the anterior maxilla (mesiodens) a specialist are important steps in or occur as para- and distomolars the treatment of mesiodens [2]. Space assessment in that jaw (see Fig. 1). These are Early diagnosis and timely surgical followed in frequency by intervention can reduce or Age determination premolars in both jaws (Fig.
    [Show full text]
  • WHAT HAPPENED? CDR, a 24-Year-Old Chinese Male
    CHILDHOOD DEVELOPMENTAL SCREENING 2020 https://doi.org/10.33591/sfp.46.5.up1 FINDING A MASS WITHIN THE ORAL CAVITY: WHAT ARE THE COMMON CAUSES AND 4-7 GAINING INSIGHT: WHAT ARE THE ISSUES? In Figure 2 below, a list of masses that could arise from each site Figure 3. Most common oral masses What are the common salivary gland pathologies Salivary gland tumours (Figure 7) commonly present as channel referrals to appropriate specialists who are better HOW SHOULD A GP MANAGE THEM? of the oral cavity is given and elaborated briey. Among the that a GP should be aware of? painless growing masses which are usually benign. ey can equipped in centres to accurately diagnose and treat these Mr Tan Tai Joum, Dr Marie Stella P Cruz CDR had a slow-growing mass in the oral cavity over one year more common oral masses are: torus palatinus, torus occur in both major and minor salivary glands but are most patients, which usually involves surgical excision. but sought treatment only when he experienced a sudden acute mandibularis, pyogenic granuloma, mucocele, broma, ere are three pairs of major salivary glands (parotid, commonly found occurring in the parotid glands. e most 3) Salivary gland pathology may be primary or secondary to submandibular and sublingual) as well as hundreds of minor ABSTRACT onset of severe pain and numbness. He was fortunate to have leukoplakia and squamous cell carcinoma – photographs of common type of salivary gland tumour is the pleomorphic systemic causes. ese dierent diseases may present with not sought treatment as it had not caused any pain.
    [Show full text]
  • Oral Mucocele – Diagnosis and Management
    Journal of Dentistry, Medicine and Medical Sciences Vol. 2(2) pp. 26-30, November 2012 Available online http://www.interesjournals.org/JDMMS Copyright ©2012 International Research Journals Review Oral Mucocele – Diagnosis and Management Prasanna Kumar Rao 1, Divya Hegde 2, Shishir Ram Shetty 3, Laxmikanth Chatra 4 and Prashanth Shenai 5 1Associate Professor, Department of Oral Medicine and Radiology, Yenepoya Dental College, Yenepoya University, Deralakatte, Nithyanandanagar Post, Mangalore, Karnataka, India. 2Assistant Professor, Department of Obstetrics and Gynecology, AJ Institute of Medical Sciences, Mangalore, Karnataka, India. 3Reader, Department of Oral Medicine and Radiology, AB Shetty Memorial Institute of Dental Sciences, Nitte University, Mangalore, Karnataka, India. 4Senior Professor and Head, Department of Oral Medicine and Radiology, Yenepoya Dental College, Yenepoya University, Deralakatte, Nithyanandanagar Post, Mangalore, Karnataka, India. 5Senior Professor, Department of Oral Medicine and Radiology, Yenepoya Dental College, Yenepoya University, Deralakatte, Nithyanandanagar Post, Mangalore, Karnataka, India. ABSTRACT Mucocele are common salivary gland disorder which can be present in the oral cavity, appendix, gall bladder, paranasal sinuses or lacrimal sac. Common location for these lesions in oral cavity is lower lip however it also presents on other locations like tongue, buccal mucosa, soft palate, retromolar pad and lower labial mucosa. Trauma and lip biting habits are the main cause for these types of lesions. These are painless lesions which can be diagnosed clinically. In this review, a method used for searching data includes various internet sources and relevant electronic journals from the Pub Med and Medline. Keywords: Mucocels, Lower lip, Retention cyst. INTRODUCTION Mucocele is defined as a mucus filled cyst that can Types appear in the oral cavity, appendix, gall bladder, paranasal sinuses or lacrimal sac (Baurmash, 2003; Clinically there are two types, extravasation and retention Ozturk et al., 2005).
    [Show full text]
  • Thoroughbred Racing
    178CSR1 Title 178 Legislative Rule West Virginia Racing Commission Series 1 Thoroughbred Racing Effective: July 9, 2014 West Virginia Racing Commission 900 Pennsylvania Avenue Suite 533 Charleston WV 25302 305.558.2150 Fax 304.558.6319 Web Site: www.racing.wv.gov 178CSR1 Table of Contents SERIES 1 THOROUGHBRED RACING ____________________________________________________________________ 1 §178-1-1. General. ____________________________________________________________________________________ 1 PART 1. DEFINITIONS. _________________________________________________________________________________ 1 §178-1-2. Definitions. _________________________________________________________________________________ 1 PART 2. GENERAL AUTHORITY. ________________________________________________________________________ 9 §178-1-3. General Authority of the Racing Commission. ______________________________________________________ 9 §178-1-4. Power Of Entry. ______________________________________________________________________________ 9 §178-1-5. Racing Commission personnel. __________________________________________________________________ 9 §178-1-6. Ejection/Exclusion. __________________________________________________________________________ 12 PART 3. RACING OFFICIALS. __________________________________________________________________________ 12 §178-1-7. General Provisions. __________________________________________________________________________ 12 §178-1-8. Stewards. __________________________________________________________________________________ 14
    [Show full text]
  • ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis
    ORIGINAL ARTICLE ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis Naykky Singh Ospina,* Alaa Al Nofal,* Irina Bancos, Asma Javed, Khalid Benkhadra, Ekta Kapoor, Aida N. Lteif, Neena Natt, and M. Hassan Murad Evidence-Based Practice Research Program (N.S.O., A.A.N., K.B., M.H.M.), Mayo Clinic, Rochester, Downloaded from https://academic.oup.com/jcem/article/101/2/427/2810551 by guest on 29 September 2021 Minnesota; Knowledge and Evaluation Research Unit (N.S.O., K.B., M.H.M.), Mayo Clinic, Rochester, Minnesota; Division of Endocrinology, Diabetes, Metabolism, and Nutrition (N.S.O., N.N., I.B.), Mayo Clinic, Rochester, Minnesota; Division of Pediatric Endocrinology and Metabolism (A.A.N., A.J., A.N.L.), Mayo Clinic, Rochester, Minnesota; Division of General Internal Medicine (E.K.), Mayo Clinic, Rochester, Minnesota 55905 Context: The diagnosis of adrenal insufficiency is clinically challenging and often requires ACTH stimulation tests. Objective: To determine the diagnostic accuracy of the high- (250 mcg) and low- (1 mcg) dose ACTH stimulation tests in the diagnosis of adrenal insufficiency. Methods: We searched six databases through February 2014. Pairs of independent reviewers se- lected studies and appraised the risk of bias. Diagnostic association measures were pooled across studies using a bivariate model. Data Synthesis: For secondary adrenal insufficiency, we included 30 studies enrolling 1209 adults and 228 children. High- and low-dose ACTH stimulation tests had similar diagnostic accuracy in adults and children using different peak serum cortisol cutoffs. In general, both tests had low sensitivity and high specificity resulting in reasonable likelihood ratios for a positive test (adults: high dose, 9.1; low dose, 5.9; children: high dose, 43.5; low dose, 7.7), but a fairly suboptimal likelihood ratio for a negative test (adults: high dose, 0.39; low dose, 0.19; children: high dose, 0.65; low dose, 0.34).
    [Show full text]
  • Iii Bds Oral Pathology and Microbiology
    III BDS ORAL PATHOLOGY AND MICROBIOLOGY Theory: 120 Hours ORAL PATHOLOGY MUST KNOW 1. Benign and Malignant Tumours of the Oral Cavity (30 hrs) a. Benign tumours of epithelial tissue origin - Papilloma, Keratoacanthoma, Nevus b. Premalignant lesions and conditions: - Definition, classification - Epithelial dysplasia - Leukoplakia, Carcinoma in-situ, Erythroplakia, Palatal changes associated with reverse smoking, Oral submucous fibrosis c. Malignant tumours of epithelial tissue origin - Basal Cell Carcinoma, Epidermoid Carcinoma (Including TNM staging), Verrucous carcinoma, Malignant Melanoma. d. Benign tumours of connective tissue origin : - Fibroma, Giant cell Fibroma, Peripheral and Central Ossifying Fibroma, Lipoma, Haemangioma (different types). Lymphangioma, Chondroma, Osteoma, Osteoid Osteoma, Benign Osteoblastoma, Tori and Multiple Exostoses. e. Tumour like lesions of connective tissue origin : - Peripheral & Central giant cell granuloma, Pyogenic granuloma, Peripheral ossifying fibroma f. Malignant Tumours of Connective tissue origin : - Fibrosarcoma, Chondrosarcoma, Kaposi's Sarcoma Ewing's sarcoma, Osteosarcoma Hodgkin's and Non Hodgkin's L ymphoma, Burkitt's Lymphoma, Multiple Myeloma, Solitary Plasma cell Myeloma. g. Benign Tumours of Muscle tissue origin : - Leiomyoma, Rhabdomyoma, Congenital Epulis of newborn, Granular Cell tumor. h. Benign and malignant tumours of Nerve Tissue Origin - Neurofibroma & Neurofibromatosis-1, Schwannoma, Traumatic Neuroma, Melanotic Neuroectodermal tumour of infancy, Malignant schwannoma. i. Metastatic
    [Show full text]
  • SNAP Cortisol Testing Guide
    SNAP® Cortisol Testing Guide Diagnosing and Treating Cases of Suspected Canine Hyperadrenocorticism or Addison’s Disease IMPORTANT: Review history of any administration of corticosteroids as these may influence the reported results. Diagnose ACTH Stimulation Test Diagnostic Protocol for Cases of Suspected Canine Hyperadrenocorticism or Addison’s Disease History, physical exam, CBC, chemistry panel, electrolytes and urinalysis consistent with Canine Hyperadrenocorticism or Addison’s disease Draw baseline cortisol sample. Perform an ACTH stimulation test with Cortrosyn® 5 µg/kg IV or ACTH gel 2.2 U/kg IM. Draw 1-hour cortisol (Cortrosyn®) or 1 and 2-hour cortisol (ACTH gel). Pre-ACTH: 2–6 µg/dL Pre- and Post-ACTH Post-ACTH Post-ACTH Post-ACTH 2 6 µg/dL >22 µg/dL <2 µg/dL – Post-ACTH: 6–18 µg/dL 18–22 µg/dL If both results are <2 µg/dL, results are Equivocal, Consistent Inconclusive consistent with Normal Cushing’s possible with Cushing’s hypoadrenocorticism Perform high-dose dexamethasone* Begin treatment with suppression to mineralocorticoid discriminate between and/or glucocorticoid PDH and ATH, as appropriate. ACTH level and/or abdominal ultrasound. * Do not exceed 0.1 mg/kg of dexamethasone. Diagnose Low-Dose Dexamethasone Suppression Protocol For Cases of Suspected Canine Hyperadrenocorticism History, physical exam, CBC, chemistry panel, electrolytes and urinalysis consistent with Canine Hyperadrenocorticism Draw baseline cortisol sample. Perform a low-dose dexamethasone suppression test with 0.01 mg/kg of dexamethasone IV. Draw 4-hour
    [Show full text]